Methylphenidate Hydrochloride (la) Capsule, Extended Release
Product Images NDC 51862-612

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (la) (NDC 51862-612). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Methylphenidate 01)

Chemical structure diagram showing the molecular formula of Methylphenidate Hydrochloride (LA), including its characteristic phenyl ring, methyl ester group, piperidine ring, and hydrochloride component.*

FDA Label Image

Figure 1 (Methylphenidate 02)

A line graph comparing mean di-methylphenidate plasma levels (ng/mL) over 24 hours for two dosage forms: Methylphenidate Hydrochloride Extended-Release Capsules (LA) 40 mg once daily and Methylphenidate Hydrochloride Tablets 20 mg twice daily. The graph shows plasma levels rising to a peak and declining over time for both regimens with data points for each hour.*

FDA Label Image

Figure 2 (Methylphenidate 03)

A bar graph comparing the mean final score minus mean baseline score for Methylphenidate Hydrochloride (LA) capsules and placebo groups. The graph includes error bars representing the standard error of the mean. Methylphenidate HCl ER Capsules show a negative mean change, while placebo shows a positive mean change.*

FDA Label Image

Principal Display Panel (60 mg Capsule Bottle Label)

Packaging label for Methylphenidate Hydrochloride Extended-Release Capsules (LA) 60 mg by Mayne Pharma. The label indicates a 30-capsule count, with instructions for dispensing with a Medication Guide. Storage conditions and manufacturer details for Mayne Pharma, Greenville, NC, are visible, along with barcode and NDC 51862-614-30.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Label for Methylphenidate Hydrochloride (LA) 10 mg extended-release capsules by Mayne Pharma. The label states once daily dosing and includes a barcode, NDC 51862-609-01, and a 100 capsule count. It highlights storage instructions and warns to keep out of reach of children, with a note to dispense with a medication guide.*

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

Label for Methylphenidate Hydrochloride Extended-Release Capsules (LA) 20 mg by Mayne Pharma. The label shows dosage form as extended-release capsules, strength as 20 mg, and package count of 100 capsules. It includes storage instructions, dispensing guidance, and a barcode. Manufacturer information lists Mayne Pharma, Greenville, NC.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Label for Methylphenidate Hydrochloride Extended-Release Capsules (LA), 30 mg strength. The label includes the proprietary name, strength, dosage form, manufacturer Mayne Pharma, storage instructions, dispensing notes, and package size of 100 capsules. The label also features a barcode and the Mayne Pharma logo.*

FDA Label Image

Principal Display Panel (40 mg Capsule Bottle Label)

Label for Methylphenidate Hydrochloride Extended-Release Capsules (LA) 40 mg by Mayne Pharma. The label includes dosage form, strength, NDC 51862-612-01, storage instructions, dispensing note, and package size of 100 capsules. It also features barcodes and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.